Global Clinical Contract Research Services Market Overview
Clinical Contract Research Services Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2019, growing at a CAGR of xx% globally.Introspective Market Research provides the newest industry data about Clinical Contract Research Services Market and industry future trends, allowing you to identify the products and end users driving revenue growth and profitability. The Clinical Contract Research Services industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Scope of the Clinical Contract Research Services Market
The main goal of this report is to help users understand the Clinical Contract Research Services market in terms of its definition, segmentation, market potential, influential trends, and challenges facing the market. In-depth research and analysis took place while preparing the report. Readers will find this report very helpful to in-depth understanding of the market.Market Segmentation
Players Covered in Clinical Contract Research Services market are :
- Covance (Lab. Corp.)
- IQVIA
- Syneos Health
- Parexel
- PRA Health Sciences
- Pharmaceutical Product Development (PPD) LLC
- Charles River
- ICON
- Wuxi AppTec
- MedPace
- Envigo Corporation
- MPI research
- Eurofins Scientific
- PARAXEL International Corporation
- ICON Plc
- Laboratory Corporation of AmericaInc.
- Labcorp
- CRL
- Crown Bioscience
- Taconic Biosciences
- Covance
- EVOTEC
- The Jackson Laboratory
- MI Bioresearch
- Champion Oncology
- Xentech
- Living Tumor Laboratory
| Clinical Contract Research Services Market - Gloabl Sales Analysis | |||
|---|---|---|---|
| Segmentations | by Type |
| |
| by Application |
| ||
| by Region |
| ||
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 4: Clinical Contract Research Services Market by Type
4.1 Clinical Contract Research Services Market Overview Snapshot and Growth Engine
4.2 Clinical Contract Research Services Market Overview
4.3 Inflammatory Bowel Diseases (IBD)
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size (2016-2028F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Inflammatory Bowel Diseases (IBD): Grographic Segmentation
4.4 Oncology
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size (2016-2028F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Oncology: Grographic Segmentation
4.5 Hematology
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size (2016-2028F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hematology: Grographic Segmentation
4.6 Infectious Diseases
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size (2016-2028F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Infectious Diseases: Grographic Segmentation
4.7 Multiple Sclerosis
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size (2016-2028F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Multiple Sclerosis: Grographic Segmentation
4.8 Rare Diseases
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size (2016-2028F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Rare Diseases: Grographic Segmentation
Chapter 5: Clinical Contract Research Services Market by Application
5.1 Clinical Contract Research Services Market Overview Snapshot and Growth Engine
5.2 Clinical Contract Research Services Market Overview
5.3 Biopharmaceutical Companies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Biopharmaceutical Companies: Grographic Segmentation
5.4 Hospital
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hospital: Grographic Segmentation
5.5 Government and Academic Research Institutions
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Government and Academic Research Institutions: Grographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Grographic Segmentation
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Positioning
6.1.2 Clinical Contract Research Services Sales and Market Share By Players
6.1.3 Industry BCG Matrix
6.1.4 Ansoff Matrix
6.1.5 Clinical Contract Research Services Industry Concentration Ratio (CR5 and HHI)
6.1.6 Top 5 Clinical Contract Research Services Players Market Share
6.1.7 Mergers and Acquisitions
6.1.8 Business Strategies By Top Players
6.2 COVANCE (LAB. CORP.)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.2.8 SWOT Analysis
6.3 IQVIA
6.4 SYNEOS HEALTH
6.5 PAREXEL
6.6 PRA HEALTH SCIENCES
6.7 PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC
6.8 CHARLES RIVER
6.9 ICON
6.10 WUXI APPTEC
6.11 MEDPACE
6.12 ENVIGO CORPORATION
6.13 MPI RESEARCH
6.14 EUROFINS SCIENTIFIC
6.15 PARAXEL INTERNATIONAL CORPORATION
6.16 ICON PLC
6.17 LABORATORY CORPORATION OF AMERICAINC.
6.18 LABCORP
6.19 CRL
6.20 CROWN BIOSCIENCE
6.21 TACONIC BIOSCIENCES
6.22 COVANCE
6.23 EVOTEC
6.24 THE JACKSON LABORATORY
6.25 MI BIORESEARCH
6.26 CHAMPION ONCOLOGY
6.27 XENTECH
6.28 LIVING TUMOR LABORATORY
Chapter 7: Global Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
7.1 Market Overview
7.2 Historic and Forecasted Market Size By Type
7.2.1 Inflammatory Bowel Diseases (IBD)
7.2.2 Oncology
7.2.3 Hematology
7.2.4 Infectious Diseases
7.2.5 Multiple Sclerosis
7.2.6 Rare Diseases
7.3 Historic and Forecasted Market Size By Application
7.3.1 Biopharmaceutical Companies
7.3.2 Hospital
7.3.3 Government and Academic Research Institutions
7.3.4 Others
Chapter 8: North America Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
8.1 Key Market Trends, Growth Factors and Opportunities
8.2 Impact of Covid-19
8.3 Key Players
8.4 Key Market Trends, Growth Factors and Opportunities
8.4 Historic and Forecasted Market Size By Type
8.4.1 Inflammatory Bowel Diseases (IBD)
8.4.2 Oncology
8.4.3 Hematology
8.4.4 Infectious Diseases
8.4.5 Multiple Sclerosis
8.4.6 Rare Diseases
8.5 Historic and Forecasted Market Size By Application
8.5.1 Biopharmaceutical Companies
8.5.2 Hospital
8.5.3 Government and Academic Research Institutions
8.5.4 Others
8.6 Historic and Forecast Market Size by Country
8.6.1 U.S.
8.6.2 Canada
8.6.3 Mexico
Chapter 9: Europe Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Inflammatory Bowel Diseases (IBD)
9.4.2 Oncology
9.4.3 Hematology
9.4.4 Infectious Diseases
9.4.5 Multiple Sclerosis
9.4.6 Rare Diseases
9.5 Historic and Forecasted Market Size By Application
9.5.1 Biopharmaceutical Companies
9.5.2 Hospital
9.5.3 Government and Academic Research Institutions
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 Germany
9.6.2 U.K.
9.6.3 France
9.6.4 Italy
9.6.5 Russia
9.6.6 Spain
Chapter 10: Asia-Pacific Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Inflammatory Bowel Diseases (IBD)
10.4.2 Oncology
10.4.3 Hematology
10.4.4 Infectious Diseases
10.4.5 Multiple Sclerosis
10.4.6 Rare Diseases
10.5 Historic and Forecasted Market Size By Application
10.5.1 Biopharmaceutical Companies
10.5.2 Hospital
10.5.3 Government and Academic Research Institutions
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 China
10.6.2 India
10.6.3 Japan
10.6.4 Southeast Asia
Chapter 11: South America Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Inflammatory Bowel Diseases (IBD)
11.4.2 Oncology
11.4.3 Hematology
11.4.4 Infectious Diseases
11.4.5 Multiple Sclerosis
11.4.6 Rare Diseases
11.5 Historic and Forecasted Market Size By Application
11.5.1 Biopharmaceutical Companies
11.5.2 Hospital
11.5.3 Government and Academic Research Institutions
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Brazil
11.6.2 Argentina
Chapter 12: Middle East & Africa Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Inflammatory Bowel Diseases (IBD)
12.4.2 Oncology
12.4.3 Hematology
12.4.4 Infectious Diseases
12.4.5 Multiple Sclerosis
12.4.6 Rare Diseases
12.5 Historic and Forecasted Market Size By Application
12.5.1 Biopharmaceutical Companies
12.5.2 Hospital
12.5.3 Government and Academic Research Institutions
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Saudi Arabia
12.6.2 South Africa
Chapter 13 Investment Analysis
Chapter 14 Analyst Viewpoint and Conclusion
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
3.5.1 Drivers
3.5.2 Restraints
3.5.3 Opportunities
3.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 4: Clinical Contract Research Services Market by Type
4.1 Clinical Contract Research Services Market Overview Snapshot and Growth Engine
4.2 Clinical Contract Research Services Market Overview
4.3 Inflammatory Bowel Diseases (IBD)
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size (2016-2028F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Inflammatory Bowel Diseases (IBD): Grographic Segmentation
4.4 Oncology
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size (2016-2028F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Oncology: Grographic Segmentation
4.5 Hematology
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size (2016-2028F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Hematology: Grographic Segmentation
4.6 Infectious Diseases
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size (2016-2028F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Infectious Diseases: Grographic Segmentation
4.7 Multiple Sclerosis
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size (2016-2028F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Multiple Sclerosis: Grographic Segmentation
4.8 Rare Diseases
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size (2016-2028F)
4.8.3 Key Market Trends, Growth Factors and Opportunities
4.8.4 Rare Diseases: Grographic Segmentation
Chapter 5: Clinical Contract Research Services Market by Application
5.1 Clinical Contract Research Services Market Overview Snapshot and Growth Engine
5.2 Clinical Contract Research Services Market Overview
5.3 Biopharmaceutical Companies
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Biopharmaceutical Companies: Grographic Segmentation
5.4 Hospital
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Hospital: Grographic Segmentation
5.5 Government and Academic Research Institutions
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Government and Academic Research Institutions: Grographic Segmentation
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Grographic Segmentation
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Positioning
6.1.2 Clinical Contract Research Services Sales and Market Share By Players
6.1.3 Industry BCG Matrix
6.1.4 Ansoff Matrix
6.1.5 Clinical Contract Research Services Industry Concentration Ratio (CR5 and HHI)
6.1.6 Top 5 Clinical Contract Research Services Players Market Share
6.1.7 Mergers and Acquisitions
6.1.8 Business Strategies By Top Players
6.2 COVANCE (LAB. CORP.)
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.2.8 SWOT Analysis
6.3 IQVIA
6.4 SYNEOS HEALTH
6.5 PAREXEL
6.6 PRA HEALTH SCIENCES
6.7 PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC
6.8 CHARLES RIVER
6.9 ICON
6.10 WUXI APPTEC
6.11 MEDPACE
6.12 ENVIGO CORPORATION
6.13 MPI RESEARCH
6.14 EUROFINS SCIENTIFIC
6.15 PARAXEL INTERNATIONAL CORPORATION
6.16 ICON PLC
6.17 LABORATORY CORPORATION OF AMERICAINC.
6.18 LABCORP
6.19 CRL
6.20 CROWN BIOSCIENCE
6.21 TACONIC BIOSCIENCES
6.22 COVANCE
6.23 EVOTEC
6.24 THE JACKSON LABORATORY
6.25 MI BIORESEARCH
6.26 CHAMPION ONCOLOGY
6.27 XENTECH
6.28 LIVING TUMOR LABORATORY
Chapter 7: Global Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
7.1 Market Overview
7.2 Historic and Forecasted Market Size By Type
7.2.1 Inflammatory Bowel Diseases (IBD)
7.2.2 Oncology
7.2.3 Hematology
7.2.4 Infectious Diseases
7.2.5 Multiple Sclerosis
7.2.6 Rare Diseases
7.3 Historic and Forecasted Market Size By Application
7.3.1 Biopharmaceutical Companies
7.3.2 Hospital
7.3.3 Government and Academic Research Institutions
7.3.4 Others
Chapter 8: North America Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
8.1 Key Market Trends, Growth Factors and Opportunities
8.2 Impact of Covid-19
8.3 Key Players
8.4 Key Market Trends, Growth Factors and Opportunities
8.4 Historic and Forecasted Market Size By Type
8.4.1 Inflammatory Bowel Diseases (IBD)
8.4.2 Oncology
8.4.3 Hematology
8.4.4 Infectious Diseases
8.4.5 Multiple Sclerosis
8.4.6 Rare Diseases
8.5 Historic and Forecasted Market Size By Application
8.5.1 Biopharmaceutical Companies
8.5.2 Hospital
8.5.3 Government and Academic Research Institutions
8.5.4 Others
8.6 Historic and Forecast Market Size by Country
8.6.1 U.S.
8.6.2 Canada
8.6.3 Mexico
Chapter 9: Europe Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Inflammatory Bowel Diseases (IBD)
9.4.2 Oncology
9.4.3 Hematology
9.4.4 Infectious Diseases
9.4.5 Multiple Sclerosis
9.4.6 Rare Diseases
9.5 Historic and Forecasted Market Size By Application
9.5.1 Biopharmaceutical Companies
9.5.2 Hospital
9.5.3 Government and Academic Research Institutions
9.5.4 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 Germany
9.6.2 U.K.
9.6.3 France
9.6.4 Italy
9.6.5 Russia
9.6.6 Spain
Chapter 10: Asia-Pacific Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Inflammatory Bowel Diseases (IBD)
10.4.2 Oncology
10.4.3 Hematology
10.4.4 Infectious Diseases
10.4.5 Multiple Sclerosis
10.4.6 Rare Diseases
10.5 Historic and Forecasted Market Size By Application
10.5.1 Biopharmaceutical Companies
10.5.2 Hospital
10.5.3 Government and Academic Research Institutions
10.5.4 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 China
10.6.2 India
10.6.3 Japan
10.6.4 Southeast Asia
Chapter 11: South America Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Inflammatory Bowel Diseases (IBD)
11.4.2 Oncology
11.4.3 Hematology
11.4.4 Infectious Diseases
11.4.5 Multiple Sclerosis
11.4.6 Rare Diseases
11.5 Historic and Forecasted Market Size By Application
11.5.1 Biopharmaceutical Companies
11.5.2 Hospital
11.5.3 Government and Academic Research Institutions
11.5.4 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Brazil
11.6.2 Argentina
Chapter 12: Middle East & Africa Clinical Contract Research Services Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Inflammatory Bowel Diseases (IBD)
12.4.2 Oncology
12.4.3 Hematology
12.4.4 Infectious Diseases
12.4.5 Multiple Sclerosis
12.4.6 Rare Diseases
12.5 Historic and Forecasted Market Size By Application
12.5.1 Biopharmaceutical Companies
12.5.2 Hospital
12.5.3 Government and Academic Research Institutions
12.5.4 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Saudi Arabia
12.6.2 South Africa
Chapter 13 Investment Analysis
Chapter 14 Analyst Viewpoint and Conclusion
| Clinical Contract Research Services Market - Gloabl Sales Analysis | |||
|---|---|---|---|
| Segmentations | by Type |
| |
| by Application |
| ||
| by Region |
| ||
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CLINICAL CONTRACT RESEARCH SERVICES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CLINICAL CONTRACT RESEARCH SERVICES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CLINICAL CONTRACT RESEARCH SERVICES MARKET COMPETITIVE RIVALRY
TABLE 005. CLINICAL CONTRACT RESEARCH SERVICES MARKET THREAT OF NEW ENTRANTS
TABLE 006. CLINICAL CONTRACT RESEARCH SERVICES MARKET THREAT OF SUBSTITUTES
TABLE 007. CLINICAL CONTRACT RESEARCH SERVICES MARKET BY TYPE
TABLE 008. INFLAMMATORY BOWEL DISEASES (IBD) MARKET OVERVIEW (2016-2028)
TABLE 009. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 010. HEMATOLOGY MARKET OVERVIEW (2016-2028)
TABLE 011. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
TABLE 012. MULTIPLE SCLEROSIS MARKET OVERVIEW (2016-2028)
TABLE 013. RARE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 014. CLINICAL CONTRACT RESEARCH SERVICES MARKET BY APPLICATION
TABLE 015. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 016. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 017. GOVERNMENT AND ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
TABLE 018. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 019. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 020. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 021. N CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 022. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 023. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 024. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 025. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 026. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 027. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 030. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 031. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 032. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 033. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 034. COVANCE (LAB. CORP.): SNAPSHOT
TABLE 035. COVANCE (LAB. CORP.): BUSINESS PERFORMANCE
TABLE 036. COVANCE (LAB. CORP.): PRODUCT PORTFOLIO
TABLE 037. COVANCE (LAB. CORP.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. IQVIA: SNAPSHOT
TABLE 038. IQVIA: BUSINESS PERFORMANCE
TABLE 039. IQVIA: PRODUCT PORTFOLIO
TABLE 040. IQVIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. SYNEOS HEALTH: SNAPSHOT
TABLE 041. SYNEOS HEALTH: BUSINESS PERFORMANCE
TABLE 042. SYNEOS HEALTH: PRODUCT PORTFOLIO
TABLE 043. SYNEOS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. PAREXEL: SNAPSHOT
TABLE 044. PAREXEL: BUSINESS PERFORMANCE
TABLE 045. PAREXEL: PRODUCT PORTFOLIO
TABLE 046. PAREXEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. PRA HEALTH SCIENCES: SNAPSHOT
TABLE 047. PRA HEALTH SCIENCES: BUSINESS PERFORMANCE
TABLE 048. PRA HEALTH SCIENCES: PRODUCT PORTFOLIO
TABLE 049. PRA HEALTH SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: SNAPSHOT
TABLE 050. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: BUSINESS PERFORMANCE
TABLE 051. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: PRODUCT PORTFOLIO
TABLE 052. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. CHARLES RIVER: SNAPSHOT
TABLE 053. CHARLES RIVER: BUSINESS PERFORMANCE
TABLE 054. CHARLES RIVER: PRODUCT PORTFOLIO
TABLE 055. CHARLES RIVER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. ICON: SNAPSHOT
TABLE 056. ICON: BUSINESS PERFORMANCE
TABLE 057. ICON: PRODUCT PORTFOLIO
TABLE 058. ICON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. WUXI APPTEC: SNAPSHOT
TABLE 059. WUXI APPTEC: BUSINESS PERFORMANCE
TABLE 060. WUXI APPTEC: PRODUCT PORTFOLIO
TABLE 061. WUXI APPTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. MEDPACE: SNAPSHOT
TABLE 062. MEDPACE: BUSINESS PERFORMANCE
TABLE 063. MEDPACE: PRODUCT PORTFOLIO
TABLE 064. MEDPACE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ENVIGO CORPORATION: SNAPSHOT
TABLE 065. ENVIGO CORPORATION: BUSINESS PERFORMANCE
TABLE 066. ENVIGO CORPORATION: PRODUCT PORTFOLIO
TABLE 067. ENVIGO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. MPI RESEARCH: SNAPSHOT
TABLE 068. MPI RESEARCH: BUSINESS PERFORMANCE
TABLE 069. MPI RESEARCH: PRODUCT PORTFOLIO
TABLE 070. MPI RESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. EUROFINS SCIENTIFIC: SNAPSHOT
TABLE 071. EUROFINS SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 072. EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 073. EUROFINS SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. PARAXEL INTERNATIONAL CORPORATION: SNAPSHOT
TABLE 074. PARAXEL INTERNATIONAL CORPORATION: BUSINESS PERFORMANCE
TABLE 075. PARAXEL INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
TABLE 076. PARAXEL INTERNATIONAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ICON PLC: SNAPSHOT
TABLE 077. ICON PLC: BUSINESS PERFORMANCE
TABLE 078. ICON PLC: PRODUCT PORTFOLIO
TABLE 079. ICON PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. LABORATORY CORPORATION OF AMERICAINC.: SNAPSHOT
TABLE 080. LABORATORY CORPORATION OF AMERICAINC.: BUSINESS PERFORMANCE
TABLE 081. LABORATORY CORPORATION OF AMERICAINC.: PRODUCT PORTFOLIO
TABLE 082. LABORATORY CORPORATION OF AMERICAINC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. LABCORP: SNAPSHOT
TABLE 083. LABCORP: BUSINESS PERFORMANCE
TABLE 084. LABCORP: PRODUCT PORTFOLIO
TABLE 085. LABCORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. CRL: SNAPSHOT
TABLE 086. CRL: BUSINESS PERFORMANCE
TABLE 087. CRL: PRODUCT PORTFOLIO
TABLE 088. CRL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. CROWN BIOSCIENCE: SNAPSHOT
TABLE 089. CROWN BIOSCIENCE: BUSINESS PERFORMANCE
TABLE 090. CROWN BIOSCIENCE: PRODUCT PORTFOLIO
TABLE 091. CROWN BIOSCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 091. TACONIC BIOSCIENCES: SNAPSHOT
TABLE 092. TACONIC BIOSCIENCES: BUSINESS PERFORMANCE
TABLE 093. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 094. TACONIC BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 094. COVANCE: SNAPSHOT
TABLE 095. COVANCE: BUSINESS PERFORMANCE
TABLE 096. COVANCE: PRODUCT PORTFOLIO
TABLE 097. COVANCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 097. EVOTEC: SNAPSHOT
TABLE 098. EVOTEC: BUSINESS PERFORMANCE
TABLE 099. EVOTEC: PRODUCT PORTFOLIO
TABLE 100. EVOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. THE JACKSON LABORATORY: SNAPSHOT
TABLE 101. THE JACKSON LABORATORY: BUSINESS PERFORMANCE
TABLE 102. THE JACKSON LABORATORY: PRODUCT PORTFOLIO
TABLE 103. THE JACKSON LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. MI BIORESEARCH: SNAPSHOT
TABLE 104. MI BIORESEARCH: BUSINESS PERFORMANCE
TABLE 105. MI BIORESEARCH: PRODUCT PORTFOLIO
TABLE 106. MI BIORESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. CHAMPION ONCOLOGY: SNAPSHOT
TABLE 107. CHAMPION ONCOLOGY: BUSINESS PERFORMANCE
TABLE 108. CHAMPION ONCOLOGY: PRODUCT PORTFOLIO
TABLE 109. CHAMPION ONCOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. XENTECH: SNAPSHOT
TABLE 110. XENTECH: BUSINESS PERFORMANCE
TABLE 111. XENTECH: PRODUCT PORTFOLIO
TABLE 112. XENTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. LIVING TUMOR LABORATORY: SNAPSHOT
TABLE 113. LIVING TUMOR LABORATORY: BUSINESS PERFORMANCE
TABLE 114. LIVING TUMOR LABORATORY: PRODUCT PORTFOLIO
TABLE 115. LIVING TUMOR LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY TYPE
FIGURE 012. INFLAMMATORY BOWEL DISEASES (IBD) MARKET OVERVIEW (2016-2028)
FIGURE 013. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 014. HEMATOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 015. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 016. MULTIPLE SCLEROSIS MARKET OVERVIEW (2016-2028)
FIGURE 017. RARE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 018. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY APPLICATION
FIGURE 019. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 020. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 021. GOVERNMENT AND ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
FIGURE 022. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 023. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. CLINICAL CONTRACT RESEARCH SERVICES MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. CLINICAL CONTRACT RESEARCH SERVICES MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. CLINICAL CONTRACT RESEARCH SERVICES MARKET COMPETITIVE RIVALRY
TABLE 005. CLINICAL CONTRACT RESEARCH SERVICES MARKET THREAT OF NEW ENTRANTS
TABLE 006. CLINICAL CONTRACT RESEARCH SERVICES MARKET THREAT OF SUBSTITUTES
TABLE 007. CLINICAL CONTRACT RESEARCH SERVICES MARKET BY TYPE
TABLE 008. INFLAMMATORY BOWEL DISEASES (IBD) MARKET OVERVIEW (2016-2028)
TABLE 009. ONCOLOGY MARKET OVERVIEW (2016-2028)
TABLE 010. HEMATOLOGY MARKET OVERVIEW (2016-2028)
TABLE 011. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
TABLE 012. MULTIPLE SCLEROSIS MARKET OVERVIEW (2016-2028)
TABLE 013. RARE DISEASES MARKET OVERVIEW (2016-2028)
TABLE 014. CLINICAL CONTRACT RESEARCH SERVICES MARKET BY APPLICATION
TABLE 015. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 016. HOSPITAL MARKET OVERVIEW (2016-2028)
TABLE 017. GOVERNMENT AND ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
TABLE 018. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 019. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 020. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 021. N CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 022. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 023. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 024. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 025. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 026. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 027. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 030. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 031. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY TYPE (2016-2028)
TABLE 032. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY APPLICATION (2016-2028)
TABLE 033. CLINICAL CONTRACT RESEARCH SERVICES MARKET, BY COUNTRY (2016-2028)
TABLE 034. COVANCE (LAB. CORP.): SNAPSHOT
TABLE 035. COVANCE (LAB. CORP.): BUSINESS PERFORMANCE
TABLE 036. COVANCE (LAB. CORP.): PRODUCT PORTFOLIO
TABLE 037. COVANCE (LAB. CORP.): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 037. IQVIA: SNAPSHOT
TABLE 038. IQVIA: BUSINESS PERFORMANCE
TABLE 039. IQVIA: PRODUCT PORTFOLIO
TABLE 040. IQVIA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. SYNEOS HEALTH: SNAPSHOT
TABLE 041. SYNEOS HEALTH: BUSINESS PERFORMANCE
TABLE 042. SYNEOS HEALTH: PRODUCT PORTFOLIO
TABLE 043. SYNEOS HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. PAREXEL: SNAPSHOT
TABLE 044. PAREXEL: BUSINESS PERFORMANCE
TABLE 045. PAREXEL: PRODUCT PORTFOLIO
TABLE 046. PAREXEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. PRA HEALTH SCIENCES: SNAPSHOT
TABLE 047. PRA HEALTH SCIENCES: BUSINESS PERFORMANCE
TABLE 048. PRA HEALTH SCIENCES: PRODUCT PORTFOLIO
TABLE 049. PRA HEALTH SCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: SNAPSHOT
TABLE 050. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: BUSINESS PERFORMANCE
TABLE 051. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: PRODUCT PORTFOLIO
TABLE 052. PHARMACEUTICAL PRODUCT DEVELOPMENT (PPD) LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. CHARLES RIVER: SNAPSHOT
TABLE 053. CHARLES RIVER: BUSINESS PERFORMANCE
TABLE 054. CHARLES RIVER: PRODUCT PORTFOLIO
TABLE 055. CHARLES RIVER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. ICON: SNAPSHOT
TABLE 056. ICON: BUSINESS PERFORMANCE
TABLE 057. ICON: PRODUCT PORTFOLIO
TABLE 058. ICON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. WUXI APPTEC: SNAPSHOT
TABLE 059. WUXI APPTEC: BUSINESS PERFORMANCE
TABLE 060. WUXI APPTEC: PRODUCT PORTFOLIO
TABLE 061. WUXI APPTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. MEDPACE: SNAPSHOT
TABLE 062. MEDPACE: BUSINESS PERFORMANCE
TABLE 063. MEDPACE: PRODUCT PORTFOLIO
TABLE 064. MEDPACE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. ENVIGO CORPORATION: SNAPSHOT
TABLE 065. ENVIGO CORPORATION: BUSINESS PERFORMANCE
TABLE 066. ENVIGO CORPORATION: PRODUCT PORTFOLIO
TABLE 067. ENVIGO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. MPI RESEARCH: SNAPSHOT
TABLE 068. MPI RESEARCH: BUSINESS PERFORMANCE
TABLE 069. MPI RESEARCH: PRODUCT PORTFOLIO
TABLE 070. MPI RESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. EUROFINS SCIENTIFIC: SNAPSHOT
TABLE 071. EUROFINS SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 072. EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 073. EUROFINS SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 073. PARAXEL INTERNATIONAL CORPORATION: SNAPSHOT
TABLE 074. PARAXEL INTERNATIONAL CORPORATION: BUSINESS PERFORMANCE
TABLE 075. PARAXEL INTERNATIONAL CORPORATION: PRODUCT PORTFOLIO
TABLE 076. PARAXEL INTERNATIONAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 076. ICON PLC: SNAPSHOT
TABLE 077. ICON PLC: BUSINESS PERFORMANCE
TABLE 078. ICON PLC: PRODUCT PORTFOLIO
TABLE 079. ICON PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 079. LABORATORY CORPORATION OF AMERICAINC.: SNAPSHOT
TABLE 080. LABORATORY CORPORATION OF AMERICAINC.: BUSINESS PERFORMANCE
TABLE 081. LABORATORY CORPORATION OF AMERICAINC.: PRODUCT PORTFOLIO
TABLE 082. LABORATORY CORPORATION OF AMERICAINC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 082. LABCORP: SNAPSHOT
TABLE 083. LABCORP: BUSINESS PERFORMANCE
TABLE 084. LABCORP: PRODUCT PORTFOLIO
TABLE 085. LABCORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 085. CRL: SNAPSHOT
TABLE 086. CRL: BUSINESS PERFORMANCE
TABLE 087. CRL: PRODUCT PORTFOLIO
TABLE 088. CRL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 088. CROWN BIOSCIENCE: SNAPSHOT
TABLE 089. CROWN BIOSCIENCE: BUSINESS PERFORMANCE
TABLE 090. CROWN BIOSCIENCE: PRODUCT PORTFOLIO
TABLE 091. CROWN BIOSCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 091. TACONIC BIOSCIENCES: SNAPSHOT
TABLE 092. TACONIC BIOSCIENCES: BUSINESS PERFORMANCE
TABLE 093. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 094. TACONIC BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 094. COVANCE: SNAPSHOT
TABLE 095. COVANCE: BUSINESS PERFORMANCE
TABLE 096. COVANCE: PRODUCT PORTFOLIO
TABLE 097. COVANCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 097. EVOTEC: SNAPSHOT
TABLE 098. EVOTEC: BUSINESS PERFORMANCE
TABLE 099. EVOTEC: PRODUCT PORTFOLIO
TABLE 100. EVOTEC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 100. THE JACKSON LABORATORY: SNAPSHOT
TABLE 101. THE JACKSON LABORATORY: BUSINESS PERFORMANCE
TABLE 102. THE JACKSON LABORATORY: PRODUCT PORTFOLIO
TABLE 103. THE JACKSON LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. MI BIORESEARCH: SNAPSHOT
TABLE 104. MI BIORESEARCH: BUSINESS PERFORMANCE
TABLE 105. MI BIORESEARCH: PRODUCT PORTFOLIO
TABLE 106. MI BIORESEARCH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. CHAMPION ONCOLOGY: SNAPSHOT
TABLE 107. CHAMPION ONCOLOGY: BUSINESS PERFORMANCE
TABLE 108. CHAMPION ONCOLOGY: PRODUCT PORTFOLIO
TABLE 109. CHAMPION ONCOLOGY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. XENTECH: SNAPSHOT
TABLE 110. XENTECH: BUSINESS PERFORMANCE
TABLE 111. XENTECH: PRODUCT PORTFOLIO
TABLE 112. XENTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112. LIVING TUMOR LABORATORY: SNAPSHOT
TABLE 113. LIVING TUMOR LABORATORY: BUSINESS PERFORMANCE
TABLE 114. LIVING TUMOR LABORATORY: PRODUCT PORTFOLIO
TABLE 115. LIVING TUMOR LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY TYPE
FIGURE 012. INFLAMMATORY BOWEL DISEASES (IBD) MARKET OVERVIEW (2016-2028)
FIGURE 013. ONCOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 014. HEMATOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 015. INFECTIOUS DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 016. MULTIPLE SCLEROSIS MARKET OVERVIEW (2016-2028)
FIGURE 017. RARE DISEASES MARKET OVERVIEW (2016-2028)
FIGURE 018. CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY APPLICATION
FIGURE 019. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 020. HOSPITAL MARKET OVERVIEW (2016-2028)
FIGURE 021. GOVERNMENT AND ACADEMIC RESEARCH INSTITUTIONS MARKET OVERVIEW (2016-2028)
FIGURE 022. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 023. NORTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. EUROPE CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. ASIA PACIFIC CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. MIDDLE EAST & AFRICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. SOUTH AMERICA CLINICAL CONTRACT RESEARCH SERVICES MARKET OVERVIEW BY COUNTRY (2016-2028)
Frequently Asked Questions :
What would be forecast period in the market research report?
The forecast period in the market research report is 2021-2025.
Who are the key players in Clinical Contract Research Services market?
The key players mentioned are Covance (Lab. Corp.), IQVIA, Syneos Health, Parexel, PRA Health Sciences, Pharmaceutical Product Development (PPD) LLC, Charles River, ICON, Wuxi AppTec, MedPace, Envigo Corporation, MPI research, Eurofins Scientific, PARAXEL International Corporation, ICON Plc, Laboratory Corporation of AmericaInc., Labcorp, CRL, Crown Bioscience, Taconic Biosciences, Covance, EVOTEC, The Jackson Laboratory, MI Bioresearch, Champion Oncology, Xentech, Living Tumor Laboratory.
What are the segments of Clinical Contract Research Services market?
The Clinical Contract Research Services market is segmented into application type, product type and region. By Application type, the market is categorized into Biopharmaceutical Companies, Hospital, Government and Academic Research Institutions, Others. By product type, it is classified into Inflammatory Bowel Diseases (IBD), Oncology, Hematology, Infectious Diseases, Multiple Sclerosis, Rare Diseases and others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain etc.), Asia-Pacific (China; India; Japan; Southeast Asia etc.), South America (Brazil; Argentina etc.), Middle East & Africa (Saudi Arabia; South Africa etc.).
What is the Clinical Contract Research Services market?
Clinical Contract Research Services Market size is projected to reach xxxx units by 2025 from an estimated xxxx unit in 2020, growing at a CAGR of xx% globally.
How big is the Clinical Contract Research Services market?
The global Clinical Contract Research Services market size was estimated at USD XX billion in 2020 and is expected to reach USD XX billion in 2025.
